Key statistics
On Monday, 4D Molecular Therapeutics Inc (FDMT:NSQ) closed at 9.08, -26.42% below its 52-week high of 12.34, set on Oct 28, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 8.92 |
|---|---|
| High | 9.18 |
| Low | 8.66 |
| Bid | 8.90 |
| Offer | 9.10 |
| Previous close | 8.99 |
| Average volume | 858.16k |
|---|---|
| Shares outstanding | 51.01m |
| Free float | 49.16m |
| P/E (TTM) | -- |
| Market cap | 463.15m USD |
| EPS (TTM) | -3.74 USD |
Data delayed at least 15 minutes, as of Feb 09 2026 21:00 GMT.
More ▼
Announcements
- 4DMT Completes Enrollment for 4FRONT-1 Phase 3 Clinical Trial of 4D-150 in Wet AMD
- 4DMT Announces New Employment Inducement Grants
- 4DMT Provides Company Update and Anticipated Development Milestones for 2026
- 4DMT Announces Positive Interim Clinical Data from 4D-710 AEROW Phase 1 Clinical Trial in Cystic Fibrosis Lung Disease
- 4DMT Announces New Employment Inducement Grants
- 4DMT to Present at the 44th Annual J.P. Morgan Healthcare Conference
- 4DMT to Participate in 8th Annual Evercore Healthcare Conference
- 4DMT Appoints Kristian Humer as Chief Financial Officer
- 4DMT Announces New Employment Inducement Grants
- 4DMT Reports Third Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
More ▼
